Zobrazeno 1 - 10
of 28
pro vyhledávání: '"F.M. Riches"'
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 3, Pp 481-488 (2000)
Abstract: We examined the effect of genetic polymorphisms of proteins regulating intrahepatic processing of apolipoprotein B-100 (apoB) and the supply of neutral lipids to the liver on the hepatic secretion of very low density lipoprotein (VLDL) apoB
Externí odkaz:
https://doaj.org/article/2d16b85b019b4fa0bf10f49879c8657b
Publikováno v:
Journal of Lipid Research, Vol 39, Iss 9, Pp 1752-1758 (1998)
We aimed to examine the effect of genetic polymorphisms of apolipoprotein B-100 (apoB) signal peptide and apolipoprotein E (apoE) on the hepatic secretion of very low density lipoprotein (VLDL) apoB in 29 men with visceral obesity. We studied apoB se
Externí odkaz:
https://doaj.org/article/6d00fcd9ba2f464b99ea63832bc7aa36
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:2854-2861
We investigated the effect of reduction in visceral obesity on the kinetics of apolipoprotein B-100 (apoB) metabolism in a controlled dietary intervention study in 26 obese men. Hepatic secretion of very low density lipoprotein (VLDL) apoB was measur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dd547bc022d25c16bcd4cdcf226d58a
https://doi.org/10.1210/jcem.84.8.5925
https://doi.org/10.1210/jcem.84.8.5925
Autor:
Gerald F. Watts, F.M. Riches, S. E. Humphries, F.M. van Bockxmeer, P.J. Talmud, Jianmin Hua, Swithin Song
Publikováno v:
Journal of Lipid Research, Vol 39, Iss 9, Pp 1752-1758 (1998)
Scopus-Elsevier
Scopus-Elsevier
We aimed to examine the effect of genetic poly- morphisms of apolipoprotein B-100 (apoB) signal peptide and apolipoprotein E (apoE) on the hepatic secretion of very low density lipoprotein (VLDL) apoB in 29 men with visceral obesity. We studied apoB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fc927d90d71fc6089706ae24e16104a
https://doi.org/10.1016/s0022-2275(20)32162-3
https://doi.org/10.1016/s0022-2275(20)32162-3
Autor:
J.M. Kelly, Gilbert R. Thompson, Gerald F. Watts, Kevin D. Croft, F.M. Riches, Rossitza P. Naoumova
Publikováno v:
Atherosclerosis. 135:83-91
Apolipoprotein B-100 (apo B) is the principal structural and functional protein of the pro-atherogenic lipoproteins, but its homeostasis in man has not been clearly established. The hepatic availability of cholesterol substrate may be a determining f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e46a8e0378675e03245c6632bf6aea
https://doi.org/10.1016/s0021-9150(97)00153-6
https://doi.org/10.1016/s0021-9150(97)00153-6
Publikováno v:
Scopus-Elsevier
We studied the effects of a hypocaloric diet with or without a serotonergic agonist (dexfenfluramine, Df) on the hepatic secretion of very-low-density-lipoprotein (VLDL) apoB and endothelial function of the forearm microcirculation in 20 viscerally o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8836bc36f64ed1c43baa2d342d1cbb
https://pubmed.ncbi.nlm.nih.gov/10751234
https://pubmed.ncbi.nlm.nih.gov/10751234
Autor:
J.M. Kelly, Kevin D. Croft, F.M. Riches, Gilbert R. Thompson, Gerald F. Watts, Rossitza P. Naoumova
Publikováno v:
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 22(5)
To test the hypothesis that the hepatic secretion of very-low-density lipoprotein (VLDL) apolipoprotein B-100 (apoB) is increased in men with visceral obesity and to examine whether the oversecretion of this apolipoprotein is related to insulin resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6fd4e7f1ee1cac0faa65ff5958653ae
https://pubmed.ncbi.nlm.nih.gov/9622338
https://pubmed.ncbi.nlm.nih.gov/9622338
Publikováno v:
Clinical and experimental pharmacologyphysiology. 24(8)
SUMMARY 1. Apolipoprotein B-100 (ApoB) is the principal structural and functional protein of the pro-atherogenic lipoproteins. Elevated plasma apoB is an independent risk factor for coronary artery disease. In the present study we aimed to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1215a3b76951c7df8a91374e20394ee5
https://pubmed.ncbi.nlm.nih.gov/9269527
https://pubmed.ncbi.nlm.nih.gov/9269527
Publikováno v:
Atherosclerosis Supplements. 2:40-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b268651df92df788ac82a3da1de9a3b8
https://doi.org/10.1016/s1567-5688(01)80036-2
https://doi.org/10.1016/s1567-5688(01)80036-2
Publikováno v:
Atherosclerosis. 144:4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::790a2639385b3843b874ab795d2b7a9a
https://doi.org/10.1016/s0021-9150(99)80008-2
https://doi.org/10.1016/s0021-9150(99)80008-2